# Renal Insufficiency trials: 131 new since Nov 2024

Updated November 18, 2026.

131 clinical studies in Renal Insufficiency were first posted on ClinicalTrials.gov from November 27, 2024 to November 18, 2026; 55 have an industry sponsor and 70 are recruiting or about to. The newest, NCT07946068, was posted on November 18, 2026: Aleniglipron Renal Impairment Study (Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics).

## The full list

New Renal Insufficiency clinical trials: 131 rows for $6.55, first posted on ClinicalTrials.gov from November 19, 2024 to November 18, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 8 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/renal-insufficiency

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 131
- Industry sponsored: 55
- Recruiting or not yet: 70
- Latest posted: November 18, 2026

## Newest trials

The newest 100 of 131, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946068 | Aleniglipron Renal Impairment Study | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | Phase 1 | Not yet recruiting | Renal Impairment, Severe Renal Impairment | 16 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946068) |
| November 16, 2026 | NCT07938034 | A Study of SYH2053 Injection in Participants With Renal Impairment Compared to Participants With Normal Renal Function | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Phase 1 | Recruiting | Renal Impairment | 24 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938034) |
| November 12, 2026 | NCT07933848 | A Study to Learn About the Study Medicine Called Prifetrastat in People With Renal Impairment | Pfizer | Phase 1 | Not yet recruiting | Renal Impairment, Healthy Adults | 24 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933848) |
| November 12, 2026 | NCT07932184 | Different Exercise Modalities in Chronic Kidney Disease: A Longitudinal Intervention Study | China Institute of Sport Science | Not applicable | Not yet recruiting | Chronic Kidney Disease (CKD), Renal Dysfunction | 80 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932184) |
| November 12, 2026 | NCT07930598 | Kidney Function Following Living Kidney Donation | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Observational | Active not recruiting | Nephrectomy,Kidney Donation, Living Kidney Donor, ESKD, Kidney Failure | 55,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930598) |
| November 9, 2026 | NCT07924930 | A Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney Function | Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company | Phase 1 | Not yet recruiting | Renal Insufficiency, Healthy Participant | 32 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924930) |
| November 6, 2026 | NCT07923071 | A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal Impairment | Syndax Pharmaceuticals | Phase 1 | Not yet recruiting | Relapsed/Refractory (R/R) Hematologic Malignancies, Acute Leukemia, Refractory Leukemia, Relapsed Leukemia | 18 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923071) |
| November 6, 2026 | NCT07922772 | Days-Off Versus Daily Initial Peritoneal Dialysis Prescription | University of Michigan | Not applicable | Not yet recruiting | Kidney Failure | 450 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922772) |
| November 6, 2026 | NCT07922174 | A Clinical Trial of MK-6916 in Participants With Moderate and Severe Kidney Disease Compared to Healthy Controls (MK-6916-013) | Merck Sharp & Dohme LLC | Phase 1 | Not yet recruiting | Healthy, Renal Impairment | 32 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922174) |
| November 6, 2026 | NCT07920926 | Hypothermic Kidney Machine Perfusion With Omnisol | Vivalyx GmbH | Not applicable | Not yet recruiting | End Stage Renal Disease (ESRD), Kidney Transplant, Kidney Failure, Renal and Urinary Tract Therapeutic Procedures | 16 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920926) |
| October 15, 2026 | NCT07874555 | A Real World Evidence Retrospective Data Collection Study of Edoxaban and Rivaroxaban | Daiichi Sankyo | Observational | Completed | Atrial Fibrillation, Renal Dysfunction | 8,265 | South Korea, Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874555) |
| October 9, 2026 | NCT07867171 | A Study to Investigate the Effects of Moderate or Severe Renal Impairment (RI) on Velzatinib | GlaxoSmithKline | Phase 1 | Not yet recruiting | Healthy Participants, Gastrointestinal Neoplasms | 30 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867171) |
| October 5, 2026 | NCT07857837 | Study of Sulthiame (S-054502) in Participants With Renal Impairment and Matched Healthy Controls | Shionogi | Phase 1 | Not yet recruiting | Renal Impairment | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07857837) |
| October 2, 2026 | NCT07854249 | A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Impaired Renal Function and Participants on... | Incyte Corporation | Phase 1 | Not yet recruiting | Renal Insufficiency, Kidney Diseases | 24 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07854249) |
| October 2, 2026 | NCT07853677 | Impact of Extrarenal Myoglobin Clearance on Renal Recovery in Patients With Severe Rhabdomyolysis | University Hospital, Strasbourg, France | Observational | Recruiting | Rhabdomyolysis-Induced Renal Failure | 100 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07853677) |
| October 1, 2026 | NCT07853131 | Study to Assess the Plasma Concentration of Rilzabrutinib Given as a Tablet to Adult Participants With Severe Renal Impairment Compared to... | Sanofi | Phase 1 | Recruiting | Renal Impairment, Healthy Volunteers | 16 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07853131) |
| September 25, 2026 | NCT07840313 | Prophylactic Desmopressin Before Native Kidney Biopsy in Severe Renal Impairment | Sindh Institute of Urology and Transplantation | Not applicable | Completed | Severe Renal Impairment | 250 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840313) |
| September 14, 2026 | NCT07818265 | Differentiating True Nephrotoxicity From Pseudo-nephrotoxicity: A Prospective Comparative Study of Vancomycin Plus Piperacillin-Tazobactam... | King Faisal Specialist Hospital & Research Center | Observational | Not yet recruiting | Nephrotoxicity, Bacterial Infections, Acute Kidney Injury, Renal Impairment | 304 | Saudi Arabia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07818265) |
| September 11, 2026 | NCT07815639 | Feasibility of the COMFORT (COmplex Symptom Management Intervention FOR adulTs With Advanced Kidney Disease) Intervention for Adults With... | University of Aarhus | Not applicable | Not yet recruiting | Chronic Kidney Disease (Stages 4 and 5) | 112 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07815639) |
| September 10, 2026 | NCT07812571 | Tenofovir Exposures in Advanced Kidney Disease Study | King's College Hospital NHS Trust | Observational | Not yet recruiting | Tenofovir, Tenofovir Alafenamide Fumarate, Chronic Kidney Diease, Kidney Failure, Pharmacokinetics | 50 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07812571) |
| September 4, 2026 | NCT07805109 | Subclinical Renal Dysfunction in Rheumatoid Arthritis | Assiut University | Observational | Not yet recruiting | Rheumatoid Arthritis, Renal Dysfunction, Chronic Kidney Diseases | 120 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805109) |
| September 3, 2026 | NCT07803237 | Predictors of Rapid CKD Progression | Assiut University | Observational | Not yet recruiting | Chronic Kidney Diseases, Kidney Failure, Chronic Renal Insufficiency, CKD, Kidney Failure, Chronic | 190 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803237) |
| September 3, 2026 | NCT07801144 | Bioimpedance-Guided Diuretics and Cardiac Progression in Asymptomatic Heart Failure | Kayseri Training and Research Hospital | Observational | Completed | Heart Failure | 80 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801144) |
| September 1, 2026 | NCT07797322 | A Study to Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to... | Novartis Pharmaceuticals | Phase 1 | Recruiting | Participants With Moderate and Severe Renal Impairment and Healthy Participants | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797322) |
| August 31, 2026 | NCT07793929 | A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide | Kailera | Phase 1 | Recruiting | End Stage Renal Disease, Renal Impairment, Obesity, Overweight | 32 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793929) |
| August 28, 2026 | NCT07792317 | Hypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation | Vivalyx GmbH | Not applicable | Recruiting | Kidney Transplant, Kidney Failure, Renal and Urinary Tract Therapeutic Procedures, End Stage Renal Disease (ESRD) | 15 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07792317) |
| August 25, 2026 | NCT07784452 | Comparing Hepatitis B Vaccination Schedules in Patients on Hemodialysis | Jinnah Hospital | Not applicable | Completed | Hepatitis B, ESRD (End Stage Renal Disease), Kidney Failure, Chronic | 104 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784452) |
| August 24, 2026 | NCT07781020 | Oral Versus Intravenous Vitamin B12 Replacement in Hemodialysis Patients | Jinnah Hospital | Not applicable | Completed | Vitamin B12 Deficiency, Renal Failure , Chronic, Renal Dialysis | 60 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781020) |
| August 14, 2026 | NCT07766707 | Local and Systemic Inflammatory Bone Alterations Related to Dental Implant Survival. | University of Barcelona | Observational | Active not recruiting | Peri Implant Mucositis, Peri Implant Bone Loss, Peri Implantitis, Calcium Deficiency, Phosphorus and Calcium Disorders... | 192 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07766707) |
| August 14, 2026 | NCT07765134 | Comprehensive Kidney Function Assessment and Early Warning in Older Adults | Huashan Hospital | Observational | Completed | Kidney Function Decline, Chronic Kidney Disease, Kidney Failure | 5,588 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07765134) |
| August 14, 2026 | NCT07765030 | Clinical Characteristics and In-Hospital Outcomes of Critically Ill Patients Receiving Hemodialysis or Continuous Venovenous... | Antalya Health Sciences University | Observational | Not yet recruiting | Acute Kidney Injury, Kidney Failure, Acute, Kidney Failure | 150 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07765030) |
| August 11, 2026 | NCT07758608 | Renal Impairment Pharmacokinetics (PK) Trial of Afabicin | Debiopharm International SA | Phase 1 | Recruiting | Renal Impairment | 60 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758608) |
| August 10, 2026 | NCT07754331 | Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin | AstraZeneca | Phase 1 | Completed | Kidney Failure | 10 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754331) |
| August 3, 2026 | NCT07741604 | A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions | Hoffmann-La Roche | Phase 1 | Recruiting | Renal Impairment | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741604) |
| July 29, 2026 | NCT07734610 | A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027) | Merck Sharp & Dohme LLC | Phase 1 | Recruiting | Severe Renal Impairment, Healthy | 20 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734610) |
| July 20, 2026 | NCT07715175 | The Study is to Investigate D-2570 in Participants With Different Levels of Kidney Function. | InventisBio Co., Ltd | Phase 1 | Recruiting | Renal Impairment | 40 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07715175) |
| July 15, 2026 | NCT07704008 | The Effect of Virtual Reality Glasses Applied to Hemodialysis Patients on Vital Signs and Anxiety Level | Ankara Yildirim Beyazıt University | Not applicable | Completed | Kidney Failure, Hemodialysis | 56 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704008) |
| July 1, 2026 | NCT07679568 | Analysis of Continuous Kidney Replacement Therapy (CKRT) Treatments With multiFlux Hemofilters Using Regional Citrate Anticoagulation (RCA)... | Fresenius Medical Care Deutschland GmbH | Observational | Not yet recruiting | Acute Kidney Injury, Renal Failure | 62 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07679568) |
| June 18, 2026 | NCT07656428 | Effect of a Focused Point-of-care Ultrasonography Screening Protocol in Hospitalized Patients | National Taiwan University Hospital | Observational | Active not recruiting | Heart Failure, Congestive, Renal Failure Acute Chronic, Liver Cirrhosis, Sepsis, Edema, Pulmonary, Establish a... | 9,000 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07656428) |
| June 9, 2026 | NCT07636083 | Acute Kidney Injury in Upper GI Bleeding Patients | Sohag University | Observational | Not yet recruiting | Upper Gastrointestinal Bleeding, Acute Kidney Injury | 200 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636083) |
| June 4, 2026 | NCT07626710 | Impact of Trans-catheter Aortic Valve Implantation on Renal Function | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | Aortic Valve Stenosis, Chronic Kidney Diseases, Renal Failure Acute Chronic | 1,000 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07626710) |
| June 1, 2026 | NCT07618858 | Comparison of Citrate and Heparin Anticoagulation During Postdilution Hemodiafiltration | University Medical Centre Ljubljana | Not applicable | Not yet recruiting | End-Stage Kidney Disease, Hemodiafiltration, Chronic Hemodialysis, Renal Failure | 20 | Slovenia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07618858) |
| May 26, 2026 | NCT07606183 | Effects of Different Forms of a Natural Heart Hormone on Blood Pressure and Fluid Balance in Healthy Volunteers | Sponsor not shown (see the record) | Early phase 1 | Completed | Heart Failure, Hypertension, Kidney Failure | 17 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07606183) |
| May 18, 2026 | NCT07593352 | Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD) | Sponsor not shown (see the record) | Observational | Recruiting | IBD and Renal Involement, Chronic Kidney Disease, Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) | 6,000 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593352) |
| April 30, 2026 | NCT07559396 | A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment... | Incyte Corporation | Phase 1 | Recruiting | Renal Impairment | 16 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07559396) |
| April 27, 2026 | NCT07551570 | Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function | Jiangsu vcare pharmaceutical technology co., LTD | Phase 1 | Completed | Renal Impairment | 32 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07551570) |
| April 24, 2026 | NCT07550790 | Contrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure | Sponsor not shown (see the record) | Not applicable | Recruiting | Heart Failure Acute, Renal Dysfunction | 190 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07550790) |
| April 15, 2026 | NCT07531173 | Serotonin Norepinephrine Reuptake Inhibitors and the Risk of Serious Adverse Events | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Observational | Active not recruiting | Chronic Kidney Disease | 8,688 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07531173) |
| April 13, 2026 | NCT07524101 | Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD | Yonsei University | Not applicable | Recruiting | Renal Insufficiency, Atherosclerosis, Dyslipidemia, Hypercholesterolemia, Cardiovascular Diseases | 1,952 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07524101) |
| March 25, 2026 | NCT07492511 | Renal and Hepatic Abnormal Doppler Patterns in Trauma | Azienda Usl di Bologna | Observational | Recruiting | Trauma (Including Fractures), Trauma Patients, Kidney Disease, Hypovolemia, Hypervolemia, Kidney Failure | 350 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07492511) |
| March 24, 2026 | NCT07489534 | Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction | Sponsor not shown (see the record) | Phase 2 | Recruiting | Multiple Myeloma | 25 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07489534) |
| March 20, 2026 | NCT07484308 | Application and Impact Assessment of Ultrasound Super-Resolution Blood Flow Imaging (URM) in Patients With Renal Failure | Sponsor not shown (see the record) | Not applicable | Completed | Kidney Failure | 150 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07484308) |
| March 17, 2026 | NCT07478575 | Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure | University Medical Centre Ljubljana | Observational | Active not recruiting | Heart Failure, Anemia, Renal Insufficiency | 85 | Slovenia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07478575) |
| March 6, 2026 | NCT07455799 | Effect of Missed Dialysis Sessions on Short Term Cardiovascular Events | Assiut University | Observational | Not yet recruiting | End Stage Renal Failure, Hemodialysis | 225 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07455799) |
| March 3, 2026 | NCT07446296 | Kidney Transplant Improvement Through New Exercise Training to Increase Capacity | University of Pennsylvania | Not applicable | Recruiting | Chronic Kidney Disease 5D, Chronic Kidney Disease Stage 5, Kidney Failure, Kidney Failure,Chronic, Renal Insufficiency... | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07446296) |
| February 23, 2026 | NCT07426380 | A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function | Eli Lilly and Company | Phase 1 | Active not recruiting | Kidney Disease, Renal Insufficiency Chronic, Kidney Failure, Chronic, Renal Impairment, Renal Insufficiency, End Stage... | 28 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07426380) |
| February 19, 2026 | NCT07421674 | Assessing Hydromorphone Sustained-Release Tablets in Elderly Cancer Pain Patients With Renal Insufficiency | Taian Cancer Hospital | Observational | Not yet recruiting | Cancer Pain, Renal Insufficiency Chronic, Hydromorphone Use | 62 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07421674) |
| February 19, 2026 | NCT07419945 | Older Kidney Patient Optimisation Pretransplant | Guy's and St Thomas' NHS Foundation Trust | Not applicable | Not yet recruiting | Kidney Disease, Kidney Failure, Frailty, Cognitive Impairment, Multimorbidity, End Stage Kidney Disease (ESRD), Kidney... | 50 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07419945) |
| January 30, 2026 | NCT07377500 | Dialysate Cooling for the Preservation of Cognitive Function in People Receiving Haemodialysis | University Hospitals of Derby and Burton NHS Foundation Trust | Not applicable | Not yet recruiting | Haemodialysis, Kidney Failure | 356 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07377500) |
| January 27, 2026 | NCT07369323 | Erector Spinae Plane Block in Kidney Transplant Pain Management | Dr. Lutfi Kirdar Kartal Training and Research Hospital | Not applicable | Completed | Kidney Failure | 40 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07369323) |
| January 27, 2026 | NCT07368712 | A Methodological Study to Learn More About Kidney Function in Healthy People and in People With Reduced Kidney Function | Bayer | Not applicable | Completed | Acute Kidney Injury, Renal Insufficiency | 33 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07368712) |
| January 26, 2026 | NCT07365644 | Prophylactic ANTicoagulation With HEparine in Critically Ill Patients With Renal Impairment | Centre Hospitalier le Mans | Observational | Not yet recruiting | Prophylactic Anticoagulation | 1,111 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07365644) |
| January 23, 2026 | NCT07364292 | Shared Decision Making in Dialysis Modality Selection: a Lived Experience From Nephrologists. A Nationwide Qualitative Study. | Erasme University Hospital | Not applicable | Completed | End Stage Renal Disease | 25 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07364292) |
| January 21, 2026 | NCT07357194 | Renal Rehabilitation Among Patients With Kidney Failure | Cairo University | Observational | Completed | Renal Failure Acute Chronic | 158 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07357194) |
| January 16, 2026 | NCT07348237 | A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006) | Merck Sharp & Dohme LLC | Phase 1 | Completed | Chronic Kidney Failure, End-Stage Renal Disease, Renal Impairment | 18 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07348237) |
| January 16, 2026 | NCT07345689 | A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations | Xuanzhu Biopharmaceutical Co., Ltd. | Phase 4 | Not yet recruiting | Hepatic Insufficiency, Renal Insufficiency, Elderly | 60 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07345689) |
| January 14, 2026 | NCT07341516 | Worldwide Assessment of Deceased Donor Kidney Utilization | Paris Translational Research Center for Organ Transplantation | Observational | Enrolling by invitation | Kidney Failure, Kidney Transplant, Deceased Donor Kidney Transplant | 300,000 | France, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07341516) |
| January 2, 2026 | NCT07315360 | A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function | Pfizer | Phase 1 | Recruiting | Renal Impairment, Healthy | 28 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07315360) |
| December 30, 2025 | NCT07309367 | Web-based Advance Care Planning Intervention for Patients With Kidney Failure on Dialysis: Pilot Testing of 'My Voice' | Duke-NUS Graduate Medical School | Not applicable | Recruiting | Kidney Failure, Chronic Therapy; Hemodialysis | 100 | Singapore | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07309367) |
| December 19, 2025 | NCT07294911 | Predictors of Contrast-induced Acute Renal Injury in Patients With Acute Coronary Syndrome | Karaganda Medical University | Observational | Completed | Acute Coronary Syndrome, Contrast-Induced Acute Kidney Injury | 88 | Kazakhstan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07294911) |
| December 19, 2025 | NCT07293936 | Post-Filter Hematocrit | Sponsor not shown (see the record) | Not applicable | Recruiting | Continuous Renal Replacement Therapy, Renal Failure, Hemofilter Clotting | 20 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07293936) |
| December 9, 2025 | NCT07271186 | Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease | Regeneron Pharmaceuticals | Phase 2 | Recruiting | Diabetic Kidney Disease (DKD) | 195 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07271186) |
| November 28, 2025 | NCT07253831 | Hand Reflexology for Fatigue and Anxiety in Hemodialysis Patients | Kufa University | Not applicable | Completed | End Stage Kidney Disease (ESRD), Hemodialysis, Anxiety, Fatigue, Reflexology | 70 | Iraq | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07253831) |
| November 26, 2025 | NCT07252401 | Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction | General Hospital of Shenyang Military Region | Not applicable | Not yet recruiting | Liver Cirrhosis | 64 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07252401) |
| November 21, 2025 | NCT07241494 | Evaluation of Clinical Pharmacy Services and Drug Use in Renal Impairment. | Istanbul University - Cerrahpasa | Not applicable | Completed | Renal Impairments, Chronic Kidney Disease, Acute Kidney Disease, Medication Errors | 160 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07241494) |
| October 20, 2025 | NCT07217886 | A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls | Shionogi | Phase 1 | Completed | Renal Impairment | 24 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07217886) |
| September 22, 2025 | NCT07185100 | Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR | German Heart Institute | Observational | Recruiting | Heart Failure With Preserved Ejection Fraction (HFPEF), Renal Dysfunction, Stage B Heart Failure | 600 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07185100) |
| September 11, 2025 | NCT07168356 | A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease | GlaxoSmithKline | Phase 1 | Active not recruiting | Hepatitis B | 32 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07168356) |
| September 10, 2025 | NCT07165015 | A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment | Eli Lilly and Company | Phase 1 | Completed | Renal Impairment, Healthy, Renal Insufficiency, End Stage Renal Disease (ESRD) | 31 | New Zealand, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07165015) |
| September 8, 2025 | NCT07160452 | Levocarnitine for Reducing ESA Requirements in Hemodialysis Patients With Renal Anemia | Shaikh Zayed Hospital, Lahore | Phase 4 | Not yet recruiting | Anemia, Kidney Failure, End-Stage Renal Disease, Renal Dialysis | 94 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07160452) |
| September 4, 2025 | NCT07156123 | PD Catheter Data Collection | Fresenius Medical Care Deutschland GmbH | Observational | Recruiting | Renal Insufficiency / Therapy | 300 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07156123) |
| September 4, 2025 | NCT07154901 | Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373) | AstraZeneca | Phase 1 | Completed | Renal Impairment | 35 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07154901) |
| August 22, 2025 | NCT07137689 | A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function | Eli Lilly and Company | Phase 1 | Completed | Renal Insufficiency | 32 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07137689) |
| August 15, 2025 | NCT07124403 | DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure | Centre Hospitalier Universitaire de Besancon | Observational | Not yet recruiting | Renal Impairment, Digestive Cancers, Breast Cancer | 742 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07124403) |
| August 12, 2025 | NCT07117409 | Retrospective Study on the Safety of Nivolumab in Patients With mRCC and Renal Failure | Azienda USL Reggio Emilia - IRCCS | Observational | Terminated | Metastatic Renal Cell Carcinoma | 81 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07117409) |
| August 3, 2025 | NCT07101055 | Pharmacokinetics of Oral Letermovir in Adults With End-Stage Kidney Disease With or Without Haemodialysis | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | End-Stage Kidney Disease (ESKD) | 20 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07101055) |
| July 20, 2025 | NCT07076030 | Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function | Zealand Pharma | Phase 1 | Completed | Renal Impairment | 39 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07076030) |
| July 10, 2025 | NCT07058909 | Premarket Clinical Safety Assessment of the ELISIO™-HX | Nipro Medical Corporation | Not applicable | Completed | Renal Failure, Acute Renal Failure, Chronic Renal Failure, Chronic Kidney Diseases, End Stage Renal Disease | 22 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07058909) |
| July 8, 2025 | NCT07053462 | CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk | AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC | Phase 1/2 | Recruiting | End-Stage Renal Disease, End Stage Renal Disease on Dialysis, End Stage Renal Disease With Renal Transplant, Kidney... | 90 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07053462) |
| June 26, 2025 | NCT07037953 | Serum circ\_DLGAP4, lncRNA KCNQ1OT1, and Their Targets by Erythropoietin Resistance in Chronic Kidney Disease | Ain Shams University | Observational | Completed | Chronic Kidney Disease Requiring Hemodialysis, Chronic Kidney Disease | 180 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07037953) |
| June 24, 2025 | NCT07033182 | Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal... | Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | Phase 1 | Completed | Infections Caused by Anaerobic Bacteria, Renal Impairment | 24 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07033182) |
| June 22, 2025 | NCT07032272 | A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched... | Novartis Pharmaceuticals | Phase 1 | Completed | Autoimmune and Chronic Inflammatory Diseases | 16 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07032272) |
| June 19, 2025 | NCT07029503 | Swedish Cardiac And Renal Failure Study-1 | Karolinska Institutet | Phase 2 | Recruiting | HFrEF - Heart Failure With Reduced Ejection Fraction, Chronic Kidney Disease | 40 | Sweden | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07029503) |
| June 13, 2025 | NCT07021014 | NightWare and Cardiovascular Health in Women With PTSD | University of Colorado, Denver | Not applicable | Recruiting | Post Traumatic Stress Disorder, Cardiovascular Diseases, Autonomic Dysfunction, Vascular Stiffness, Nightmare... | 36 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07021014) |
| June 13, 2025 | NCT07020559 | Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized Controlled Trial | Peking University Third Hospital | Phase 4 | Not yet recruiting | Diabetic Wounds, Platelet Rich Plasma, Allogeneic Blood Transfusions, Renal Dysfunction | 56 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07020559) |
| June 12, 2025 | NCT07017933 | Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes | 3ive Labs | Not applicable | Recruiting | Renal Impairment After Cardiac Surgery, Renal Impairment, Acute Kidney Injury | 124 | Poland, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07017933) |
| June 10, 2025 | NCT07012005 | Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls | Shionogi | Phase 1 | Completed | Renal Impairment | 14 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07012005) |
| June 3, 2025 | NCT07001436 | A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy... | Henan Genuine Biotech Co., Ltd. | Phase 1 | Recruiting | Renal Insufficiency | 40 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07001436) |
| May 21, 2025 | NCT06983509 | Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement Therapy | Vantive Health LLC | Observational | Completed | Renal Insufficiency | 228 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06983509) |
| May 16, 2025 | NCT06976762 | Near-Infrared Spectroscopy Measurements in Chronic Obstructive Pulmonary Disease | Tokat Gaziosmanpasa University | Observational | Enrolling by invitation | Microcirculatory Status, Spectroscopic Analysis, COPD, Renal Failure | 140 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06976762) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Merck Sharp & Dohme LLC | 4 | November 6, 2026 |
| AstraZeneca | 4 | August 10, 2026 |
| Pfizer | 3 | November 12, 2026 |
| Shionogi | 3 | October 5, 2026 |
| Assiut University | 3 | September 4, 2026 |
| Eli Lilly and Company | 3 | February 23, 2026 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 | November 12, 2026 |
| Vivalyx GmbH | 2 | November 6, 2026 |
| GlaxoSmithKline | 2 | October 9, 2026 |
| Incyte Corporation | 2 | October 2, 2026 |
| Novartis Pharmaceuticals | 2 | September 1, 2026 |
| Jinnah Hospital | 2 | August 25, 2026 |
| Fresenius Medical Care Deutschland GmbH | 2 | July 1, 2026 |
| Sohag University | 2 | June 9, 2026 |
| University Medical Centre Ljubljana | 2 | June 1, 2026 |
| Ain Shams University | 2 | June 26, 2025 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2 | December 6, 2024 |
| Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 1 | November 18, 2026 |
| CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 1 | November 16, 2026 |
| China Institute of Sport Science | 1 | November 12, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 42 | November 12, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 41 | November 18, 2026 |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 33 | November 12, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 5 | March 24, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 4 | January 16, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 2 | May 26, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 2 | December 6, 2024 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 1 | July 8, 2025 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 1 | March 10, 2025 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 39 | November 18, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 18 | November 16, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 9 | September 3, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 8 | August 11, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 6 | June 9, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 4 | June 4, 2026 |
| [South Korea](https://specstream.ai/data/clinical-trials/country/south-korea) | 3 | October 15, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 3 | October 2, 2026 |
| [Pakistan](https://specstream.ai/data/clinical-trials/country/pakistan) | 3 | September 25, 2026 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 3 | May 18, 2026 |
| [Greece](https://specstream.ai/data/clinical-trials/country/greece) | 3 | April 2, 2025 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 2 | October 15, 2026 |
| [Denmark](https://specstream.ai/data/clinical-trials/country/denmark) | 2 | September 11, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 2 | September 10, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 2 | August 14, 2026 |
| [Slovenia](https://specstream.ai/data/clinical-trials/country/slovenia) | 2 | June 1, 2026 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 2 | April 2, 2025 |
| [Saudi Arabia](https://specstream.ai/data/clinical-trials/country/saudi-arabia) | 1 | September 14, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 1 | August 28, 2026 |
| [Belgium](https://specstream.ai/data/clinical-trials/country/belgium) | 1 | January 23, 2026 |
| [Singapore](https://specstream.ai/data/clinical-trials/country/singapore) | 1 | December 30, 2025 |
| [Kazakhstan](https://specstream.ai/data/clinical-trials/country/kazakhstan) | 1 | December 19, 2025 |
| [Iraq](https://specstream.ai/data/clinical-trials/country/iraq) | 1 | November 28, 2025 |
| [New Zealand](https://specstream.ai/data/clinical-trials/country/new-zealand) | 1 | September 10, 2025 |
| [Sweden](https://specstream.ai/data/clinical-trials/country/sweden) | 1 | June 19, 2025 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Textile manufacturers in the United States](https://specstream.ai/data/businesses/textile-manufacturers/united-states)
- [Car manufacturers in the United States](https://specstream.ai/data/businesses/car-manufacturers/united-states)
- [Home inspectors in the United States](https://specstream.ai/data/businesses/home-inspectors/united-states)
- [Printing companies in the United States](https://specstream.ai/data/businesses/printing-companies/united-states)
- [Aircraft parts suppliers in the United States](https://specstream.ai/data/businesses/aircraft-parts-suppliers/united-states)
- [Drywall contractors in the United States](https://specstream.ai/data/businesses/drywall-contractors/united-states)
